Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives
Related Experiment Video
Updated: Jan 3, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Frank J T Staal1, Alessandro Aiuti2,3, Marina Cavazzana4
1Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center, Leiden, Netherlands.
Abstract:
Gene therapy using patient's own stem cells is rapidly becoming an alternative to allogeneic stem cell transplantation, especially when suitably compatible donors cannot be found. The advent of efficient virus-based methods for delivering therapeutic genes has enabled the development of genetic medicines for inherited disorders of the immune system, hemoglobinopathies, and a number of devastating metabolic diseases. Here, we briefly review the state of the art in the field, including gene editing approaches. A growing number of pediatric diseases can be successfully cured by hematopoietic stem-cell-based gene therapy.
Related Concept Videos
Gene Therapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Stem Cell Culture
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells

